Evidence map›Paper›PMID 34662534›Full record

ArticlemAbs

Antibody mix-and-read assays based on fluorescence intensity probes.

Ujwal Patil, Atul Goyal, Binh Vu, Yanyun Liu, Vijay Maranholkar, Katerina Kourentzi, James M Briggs, Richard C Willson

Open access · goldAbstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Ujwal PatilDepartment of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
Atul GoyalWilliam A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, USA.
Binh VuWilliam A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, USA.
Yanyun LiuDepartment of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
Vijay MaranholkarDepartment of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
Katerina KourentziWilliam A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, USA.
James M BriggsDepartment of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
Richard C WillsonDepartment of Biology and Biochemistry, University of Houston, Houston, Texas, USA.ORCID 0000-0002-0900-6148
University of Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies and Fc fusion proteins are a rapidly growing class of pharmaceuticals. Cell culture and purification process development and operation require frequent measurement of product concentrations, commonly by complex enzyme-linked immunosorbent assay and high-performance liquid chromatography methods. Here we report a fast (<30 s), and simple antibody Fc assay based on mix-and-read reporting by fluorescence emission. A soluble fluorescein-labeled Fc-affinity reporter produced by standard peptide synthesis is mixed with an Fc-containing sample to produce an immediate shift in both fluorescence polarization and intensity, compatible with on- and at-line measurements and microbioreactor monitoring. We observed significant shifts in fluorescence intensity in Chinese hamster ovary cell culture fluid spiked with IgG and detected an adalimumab biosimilar down to 100 ng/mL (10

Indexed as

Immunoglobulin Fc FragmentsStaphylococcal Protein AAnimalsCHO CellsCricetinaeCricetulusMolecular Docking SimulationImmunoglobulin Fc FragmentsStaphylococcal Protein Aaffinity peptidefluorescencehigh-throughputIGG titerMonoclonal antibodyproductivity screening

Identifiers

PMID34662534
PMCPMC8525972
OpenAlexW3205858594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.